Bristol Myers Squibb Co (BMY)

On March 24, Reuters reported that Barclays raised its 2026 year-end S&P 500 target.

Blue-chip stocks refer to shares of large, well-established companies that lead their industries. These businesses are typically financially strong, which makes them less risky compared to others.

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best pharma stocks to invest in now. Bristol-Myers Squibb Company (NYSE:BMY) announced on March 29 positive data from the Phase 3 SCOUT-HCM trial...

On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.

Ariel Investments, an investment management company, released its "Ariel Global Fund" fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Large-cap stocks are usually issued by established companies with long track records. These are often well-known names that have been operating for years.

Is BMY a good stock to buy? We came across a bullish thesis on Bristol-Myers Squibb Company on MaxDividends’s Substack by Serhio MaxDividends.

Bristol-Myers Squibb Company (NYSE:BMY) is facing mixed analyst sentiment, with roughly 60% of covering analysts maintaining mixed ratings on the stock.

According to the report, geopolitical tensions, particularly the ongoing armed conflict in Iran, are weighing heavily on economists, who believe higher oil prices and broader uncertainty are intensifying...